What Is Degenerative Disc Disease?

Degenerative disc disease (DDD) describes age-related structural changes to spinal discs — dehydration, height loss, and breakdown of the outer annular fibers. Despite its name, DDD is not a disease. It is a universal biological process. Most people with DDD visible on MRI have no symptoms; pain develops only when structural changes irritate nerves or destabilize surrounding tissue.

Being told you have degenerative disc disease does not put you on an automatic path to surgery. Back pain is the leading cause of disability worldwide, and DDD is among the most common findings on spinal imaging. Understanding what DDD actually is — and what it is not — is the foundation for making informed decisions about care. For a broader look at options, the Valor team’s resource on non-surgical spine treatment covers the full evidence-based landscape.

The label matters: calling a normal aging process a “disease” creates unnecessary alarm and, in many cases, steers patients toward invasive interventions that research does not consistently support. Back surgery carries roughly a 40% failure rate for achieving the patient’s desired outcome, and nearly 1 in 5 patients told they need spine surgery choose not to have it. Understanding the biology of disc degeneration helps patients ask better questions and explore the complete range of care available to them.

Is DDD Actually a Disease?

DDD is not a disease in the clinical sense — it is a spectrum of structural changes that occurs as part of normal spinal aging. The term entered clinical use as a label for imaging findings showing disc wear, but the word “disease” implies an abnormal process. Disc degeneration is, by contrast, expected biology.

A more accurate framing: DDD marks the transition of intervertebral discs from hydrated, flexible shock absorbers in youth to desiccated, less resilient structures over time. When those changes remain asymptomatic, DDD is simply an imaging finding. When they produce annular tears, disc protrusion, or facet overload, symptoms develop. The structural findings on your MRI and how you feel clinically are two separate conversations — and both matter.

How Does Disc Degeneration Develop?

Intervertebral discs consist of two main components: the nucleus pulposus (the gelatinous inner core) and the annulus fibrosus (the tough outer ring of interwoven collagen fibers). After adolescence, the disc has limited blood supply and depends on diffusion for nutrients, making it one of the most vulnerable structures in the body to cumulative mechanical stress.

Degeneration typically follows a predictable sequence:

• Nucleus dehydration — The nucleus pulposus loses proteoglycan content, reducing its water-binding capacity. The disc shrinks and loses shock-absorbing function.
• Disc height loss — As the nucleus dehydrates, vertical disc height decreases. This narrows the intervertebral foramen and increases the risk of nerve root compression.
• End-plate changes — The cartilaginous end-plates develop fissures and sclerosis. Modic changes visible on MRI reflect end-plate involvement and correlate with pain in some patients.
• Annular fiber breakdown — Circumferential and radial tears develop in the outer annulus fibrosus. When these tears reach the outer third of the annulus — where nociceptive nerve fibers reside — they generate pain directly. Annular tears also create the structural pathway for disc material to herniate outward. For a deeper look at discogenic back pain, the Valor team has a dedicated guide.
• Facet overload — As disc height decreases, the posterior facet joints bear increased compressive load, accelerating lumbar spondylosis and contributing to the broader picture of spinal degeneration.

DDD Severity Grades: The Pfirrmann Classification

Radiologists use the Pfirrmann grading system (Grade 1–5) to classify disc degeneration severity on MRI. Understanding your grade helps contextualize treatment conversations.

Pfirrmann grade alone does not determine treatment. A clinical evaluation is the only way to know for certain which options are appropriate for your specific findings.

What Are the Symptoms of Degenerative Disc Disease?

DDD symptoms vary widely — from none at all to persistent, function-limiting pain. The most common presentations include:

• Axial back or neck pain — Pain localized to the spine, often described as a dull ache that worsens with prolonged sitting, bending, or lifting.
• Radiculopathy — Sharp, shooting, or burning pain that travels into the arm or leg when a degenerated disc compresses or irritates a nerve root.
• Morning stiffness — Stiffness that eases after movement, reflecting the disc’s loss of hydration and flexibility.
• Pain with position changes — Discomfort when transitioning from sitting to standing, or after prolonged static postures.
• Referred pain — Diffuse aching in the hips, buttocks, or shoulders that does not follow a clear nerve distribution pattern.

Symptoms that worsen progressively, or that include neurological changes such as weakness, numbness, or bowel and bladder dysfunction, require prompt clinical evaluation. These presentations may indicate a condition outside the scope of conservative or minimally invasive management.

How Is DDD Diagnosed?

Diagnosis combines imaging findings with a clinical history and physical examination. MRI is the primary imaging modality for evaluating disc degeneration — it captures disc hydration, height, and annular integrity in detail that X-ray cannot provide. CT imaging adds detail on bony anatomy and end-plate changes. For patients whose pain does not correlate clearly with MRI findings, an annulogram (an imaging-guided diagnostic injection) identifies which specific discs are generating pain and maps the location of annular tears before any treatment decision is made.

The Valor team’s clinical staff reviews existing MRI studies at no cost as a starting point for evaluating whether a patient’s findings align with what the fibrin procedure addresses.

What Non-Surgical Options Exist for DDD-Related Pain?

Non-surgical care is the appropriate first line for most patients with DDD-related pain. The evidence-based options span a spectrum from conservative to minimally invasive:

• Physical therapy and core stabilization — Structured PT addresses muscular support of the spine and movement patterns that reduce disc load. Effective for many patients with Grades I–III degeneration.
• Activity modification and posture education — Reducing sustained compressive loading and correcting posture reduces symptom provocation without tissue-level intervention.
• Analgesics and anti-inflammatories — NSAIDs and acetaminophen provide symptomatic relief but do not address disc structure.
• Epidural steroid injections (ESIs) — An AAFP systematic review found ESIs not effective for chronic low back pain. They remain an option for short-term radicular symptom management in some patients, but the evidence for sustained relief is limited.
• Spinal decompression therapy — Outcomes data shows 36.8% of patients demonstrated sustained improvement at 6 months. Individual outcomes vary.
• PRP (platelet-rich plasma) — 47% of patients achieved 50% or greater pain relief at 6 months in outcomes meta-analysis data. Individual outcomes vary.
• Intra-annular fibrin injection (fibrin disc treatment) — For patients whose pain originates from annular tears and who have not found lasting relief through conservative care, an FDA-approved fibrin sealant is injected under imaging guidance to seal the tears and support the disc’s natural healing environment. Among the most-tracked outcomes — over 7,000 procedures with long-term follow-up — the success rate is 83%. Individual outcomes vary.

When Does DDD Require Surgery?

Surgery is appropriate for a specific subset of patients — those with progressive neurological deficits, spinal instability that cannot be managed conservatively, or structural compromise that places the spinal cord or nerve roots at acute risk. For patients without those indications, surgery is not the only remaining option when conservative care has stalled. A clinical evaluation determines which category a patient falls into and what the appropriate next steps are.

For patients who have already undergone surgery without achieving their desired outcome, the fibrin procedure has been studied in failed-surgery populations — 80% of failed surgery patients reported positive outcomes with fibrin injection, with individual outcomes varying. The progression from disc degeneration to spondylosis also shapes what surgical and non-surgical options are on the table.

Frequently Asked Questions

Is degenerative disc disease permanent?

DDD represents structural changes to the disc that are not reversible in the sense of restoring a disc to its youthful state. However, symptoms are not necessarily permanent. Many patients achieve sustained pain reduction through conservative care, minimally invasive procedures, or a combination of approaches. The goal of treatment is functional improvement and pain reduction, not reversal of aging-related disc changes.

Does degenerative disc disease always get worse?

Not necessarily. Degeneration progresses at varying rates based on genetics, mechanical loading, and lifestyle factors. Some patients plateau at a stable grade for years. Others progress more rapidly. Regular clinical follow-up and a structured care plan are the most reliable ways to monitor progression and intervene before structural changes become more limiting.

Can DDD cause leg pain?

Yes. When a degenerated disc compresses or irritates a nearby nerve root, pain can radiate into the leg — a pattern called radiculopathy or sciatica. Leg pain, numbness, or weakness in the context of DDD warrants clinical evaluation to determine which disc level is involved and whether the nerve compression requires intervention.

What is an annular tear and how does it relate to DDD?

An annular tear is a fissure in the outer collagen ring (annulus fibrosus) of a spinal disc. Annular fiber breakdown is a direct consequence of disc degeneration. When these tears reach the outer annular fibers — where nociceptive nerves are present — they become a direct pain source. The intra-annular fibrin injection is designed specifically to seal these tears and support the disc’s healing environment.

How is the fibrin procedure different from an epidural steroid injection?

An epidural steroid injection delivers anti-inflammatory medication into the epidural space around the disc — it does not address disc structure. The fibrin disc treatment delivers an FDA-approved fibrin sealant directly into the disc through a thin catheter, targeting the annular tears themselves. The two procedures address different aspects of disc-related pain and are not interchangeable.

Is a clinical evaluation required before the fibrin procedure?

A clinical evaluation is the only way to know for certain whether a patient is a candidate for the fibrin procedure. Candidacy depends on the specific MRI findings, the patient’s symptom pattern, prior treatment history, and overall health status. The Valor team offers a no-cost MRI review as an initial step.

Can veterans access the fibrin procedure through the VA?

Under the Mission Act, the procedure may be a covered VA benefit when the VA cannot provide timely or appropriate care. VA coverage is determined case-by-case by the VA, not by Valor Spine. The Valor team works directly with VA referral coordinators and handles the paperwork on the patient’s behalf so veterans do not have to navigate the process alone.

Learn more about discogenic back pain and how disc tears cause symptoms →

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.